As the pandemic continues, the Carterra LSA accelerates antibody discovery and enables immunity monitoring of COVID-19 patients.

Carterra is working with the Bill and Melinda Gates Foundation to screen hundreds of antibodies that target COVID-19 and rapidly move therapeutic candidates to the clinic.

Posted by John McKinley